A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial

  1. Cannata-Andía, J.B.
  2. Díaz-Sottolano, A.
  3. Fernández, P.
  4. Palomo-Antequera, C.
  5. Herrero-Puente, P.
  6. Mouzo, R.
  7. Carrillo-López, N.
  8. Panizo, S.
  9. Ibañez, G.H.
  10. Cusumano, C.A.
  11. Ballarino, C.
  12. Sánchez-Polo, V.
  13. Pefaur-Penna, J.
  14. Maderuelo-Riesco, I.
  15. Calviño-Varela, J.
  16. Gómez, M.D.
  17. Gómez-Alonso, C.
  18. Cunningham, J.
  19. Naves-Díaz, M.
  20. Douthat, W.
  21. Fernández-Martín, J.L.
Aldizkaria:
BMC medicine

ISSN: 1741-7015

Argitalpen urtea: 2022

Alea: 20

Zenbakia: 1

Orrialdeak: 83

Mota: Artikulua

DOI: 10.1186/S12916-022-02290-8 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus